OurBrainBank UK collaborating with RareCan to improve access to clinical trials
Learn about OurBrainBank UK and RareCan collaboration.
Learn about OurBrainBank UK and RareCan collaboration.
Read the fascinating series on brain tumors, glioblastoma, technological potential, and stories of patient power.
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.
NW Biotherapeutics, maker of DC Vax to treat glioblastoma — applied for approval in the UK.